Hyperosmia after COVID-19: hedonic perception or hypersensitivity?
Di Stadio A, D'Ascanio L, De Luca P, Roccamatisi D, La Mantia I, Brenner MJ.
Eur Rev Med Pharmacol Sci. 2022 Mar;26(6):2196-2200. doi: 10.26355/eurrev_202203_28368.
Hyperosmia in Lyme disease.
Puri BK, Monro JA, Julu PO, Kingston MC, Shah M.
Arq Neuropsiquiatr. 2014 Aug;72(8):596-7. doi: 10.1590/0004-282x20140109.
Case Report of Probable Duloxetine-Induced Hyperosmia.
Gündoğmuş İ, Ünsal C, Taşci AB, Uçar H, Bolu A, Öznur T, Özmenler KN.
Clin Neuropharmacol. 2020 Mar/Apr;43(2):54. doi: 10.1097/WNF.0000000000000381.
Olfactory Nomenclature: An Orchestrated Effort to Clarify Terms and Definitions of Dysosmia, Anosmia, Hyposmia, Normosmia, Hyperosmia, Olfactory Intolerance, Parosmia, and Phantosmia/Olfactory Hallucination.
Hernandez AK, Landis BN, Altundag A, Fjaeldstad AW, Gane S, Holbrook EH, Huart C, Konstantinidis I, Lechner M, Macchi A, Portillo Mazal P, Miwa T, Philpott CM, Pinto JM, Poletti SC, Vodicka J, Welge-Luessen A, Whitcroft KL, Hummel T.
ORL J Otorhinolaryngol Relat Spec. 2023;85(6):312-320. doi: 10.1159/000530211. Epub 2023 Apr 14.
Methotrexate, hyperosmia, and migraine.
Zargari O.
Dermatol Online J. 2006 Dec 10;12(7):28.
Hyperosmia and Hypergeusia As Potential Clues in Diagnosing Adrenal Insufficiency: A Case Report.
Shimazaki S, Hashimoto E, Kuno H, Maeno T, Matsumoto N, Suzuki M, Maeno T.
Cureus. 2024 Apr 25;16(4):e59038. doi: 10.7759/cureus.59038. eCollection 2024 Apr.
Greater hippocampal gray matter volume in subjective hyperosmia: a voxel-based morphometry study.
Han P, Stiller-Stut FP, Fjaeldstad A, Hummel T.
Sci Rep. 2020 Nov 2;10(1):18869. doi: 10.1038/s41598-020-75898-6.
Self-Reported Hypersensitivity to Smells: Objective Evidence for Hyposmia, not Hyperosmia.
Khan R, Moein ST, Doty RL.
Otolaryngol Head Neck Surg. 2024 Nov;171(5):1545-1551. doi: 10.1002/ohn.869. Epub 2024 Jul 5.
Duloxetine improves hyperosmia in mice with pancreatic cancer by increasing dopamine levels in the olfactory bulb.
Kuramochi T, Itaya T, Oshima Y, Kim J, Kitajima O, Nakamura T, Homma T, Ijichi H, Sano M, Suzuki T.
Biomed Pharmacother. 2025 Jun;187:118098. doi: 10.1016/j.biopha.2025.118098. Epub 2025 May 1.
Hyperosmia, ectrodactyly, mild intellectual disability, and other defects in a male patient with an X-linked partial microduplication and overexpression of the KAL1 gene.
Sowińska-Seidler A, Piwecka M, Olech E, Socha M, Latos-Bieleńska A, Jamsheer A.
J Appl Genet. 2015 May;56(2):177-84. doi: 10.1007/s13353-014-0252-7. Epub 2014 Oct 23.
